PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

  • Домашняя страница
    • О сайте
  • Материалы
    • Быстрые команды R Project
    • Ссылки
  • Инструменты
    • Рандомизационный список
  • Блог
    • Статистика
    • Phoenix WinNonlin
    • IT
    • Путевые заметки
  • Контакты
    • Контактные данные
    • Консультации
    • Конфиденциальность
  • Профиль
    • Настройки учетной записи
    • Выйти
    • Войти
    • Зарегистрироваться

Julia:ReplicateBE – release 0.2.0

Опубликовано 26 октября, 201926 октября, 2019 frozencat

doiGitHub

Вот и подоспел релиз 0.2.0 для оценки параметров смешанной модели репликативного дизайна биоэквивалентности по методу С (EMA) – FDA model.

 

Рубрики: IT, Julia, Mixed Model, Биоэквивалентность

Навигация по записям

Предыдущая запись: ClinicalTrialUtilities: обзор
Следующая запись: Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4

Свежие записи

  • Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
  • Главные ошибки при формировании базы данных в MS Excel
  • Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
  • Julia:ReplicateBE – release 0.2.0
  • ClinicalTrialUtilities: обзор

Галерея

DJI 0074
20180814 193547
20180811 170829
IMG-20170806-WA0050
20180814 180918
DJI 0001
  • FDA Approves First Oral Treatment for Anemia Caused by Chronic Kidney Disease for Adults on Dialysis
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-02 By FDA
  • Project Orbis
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-02 By FDA
  • CDER Small Business & Industry Assistance (SBIA)
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • PDUFA Performance Reports
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • IBSA Pharma Inc. Issues Voluntary Nationwide Recall of Select Lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution Due to Subpotency
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • CDERLearn Training and Education
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • CDER Manual of Policies & Procedures | MAPP
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • Best Practices for Topical Generic Product Development and ANDA Submission - 08/11/2022
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • Patient Listening Session Summaries
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • 2023 Meeting Materials, Vaccines and Related Biological Products Advisory Committee
    Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2023-02-01 By FDA
  • M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • Ongoing | Cancer Accelerated Approvals
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • FDA issues guidance to help increase supply of ibuprofen oral suspension products in hospitals and health systems
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • La FDA publica una guía para ayudar a aumentar el suministro de ibuprofeno en suspensión oral en hospitales y centros de salud
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
  • Registered Outsourcing Facilities
    Source: FDA - What's New: Drugs RSS Feed Published on 2023-02-01 By FDA
Предыдущие записи
Тема: Scaffold от Danny Cooper.